This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Higuchi, K. Articles by Yoshimatsu, H. Search for Related Content PubMed PubMed Citation Articles by Higuchi, K. Articles by Yoshimatsu, H.

Apelin, an APJ Receptor Ligand, Regulates Body Adiposity and Favors the Messenger Ribonucleic Acid Expression of Uncoupling Proteins in Mice

Department of Anatomy, Biology, and Medicine, Internal Medicine 1, Faculty of Medicine, Oita University, Oita 879-5593, Japan

Address all correspondence and requests for reprints to: Hironobu Yoshimatsu, M.D., Ph.D., Department of Anatomy, Biology, and Medicine, Internal Medicine 1, Faculty of Medicine, Oita University, 1-1 Idai-ga-oka, Hasama-cho, Yufu-city, Oita 879-5593, Japan. E-mail: higukei{at}med.oita-u.ac.jp.

Apelin, the endogenous ligand of the APJ receptor, has been identified in a variety of tissues, including stomach, heart, skeletal muscle, and white adipose tissue. We sought to clarify the effects of apelin on body adiposity and the expression of uncoupling proteins (UCPs) in C57BL/6 mice. Treatment with ip apelin at a dose of 0.1 µmol/kg·d for 14 d decreased the weight of white adipose tissue and serum levels of insulin and triglycerides, compared with controls, without influencing food intake. Apelin treatment also decreased body adiposity and serum levels of insulin and triglycerides in obese mice fed a high-fat diet. Apelin increased the serum adiponectin level and decreased that of leptin. Additionally, apelin treatment increased mRNA expression of UCP1, a marker of peripheral energy expenditure, in brown adipose tissue (BAT) and of UCP3, a regulator of fatty acid export, in skeletal muscle. In addition, immunoblot bands and relative densities of UCP1 content in BAT were also higher in the apelin group than controls. Furthermore, apelin treatment increased body temperature and O₂ consumption and decreased the respiratory quotient. In conclusion, apelin appears to regulate adiposity and lipid metabolism in both lean and obese mice. In addition, apelin regulates insulin resistance by influencing the circulating adiponectin level, the expression of BAT UCP1, and energy expenditure in mice.

This article has been cited by other articles:

				B. C. Frier, D. B. Williams, and D. C. Wright The effects of apelin treatment on skeletal muscle mitochondrial content Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2009; 297(6): R1761 - R1768. [Abstract] [Full Text] [PDF]

				J. J. Maguire, M. J. Kleinz, S. L. Pitkin, and A. P. Davenport [Pyr1]Apelin-13 Identified as the Predominant Apelin Isoform in the Human Heart: Vasoactive Mechanisms and Inotropic Action in Disease Hypertension, September 1, 2009; 54(3): 598 - 604. [Abstract] [Full Text] [PDF]